DK209188D0 - Bifunktionelle proteiner, deres fremstilling og anvendelse som laegemiddel - Google Patents

Bifunktionelle proteiner, deres fremstilling og anvendelse som laegemiddel

Info

Publication number
DK209188D0
DK209188D0 DK209188A DK209188A DK209188D0 DK 209188 D0 DK209188 D0 DK 209188D0 DK 209188 A DK209188 A DK 209188A DK 209188 A DK209188 A DK 209188A DK 209188 D0 DK209188 D0 DK 209188D0
Authority
DK
Denmark
Prior art keywords
medicine
preparation
bifunctional proteins
bifunctional
proteins
Prior art date
Application number
DK209188A
Other languages
English (en)
Other versions
DK209188A (da
DK170741B1 (da
Inventor
Paul Habermann
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK209188D0 publication Critical patent/DK209188D0/da
Publication of DK209188A publication Critical patent/DK209188A/da
Application granted granted Critical
Publication of DK170741B1 publication Critical patent/DK170741B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK209188A 1987-04-16 1988-04-15 Bifunktionelle proteiner, deres fremstilling, et lægemiddel deraf og anvendelse deraf til fremstilling af et lægemiddel DK170741B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19873712985 DE3712985A1 (de) 1987-04-16 1987-04-16 Bifunktionelle proteine
DE3712985 1987-04-16

Publications (3)

Publication Number Publication Date
DK209188D0 true DK209188D0 (da) 1988-04-15
DK209188A DK209188A (da) 1988-10-17
DK170741B1 DK170741B1 (da) 1996-01-08

Family

ID=6325799

Family Applications (1)

Application Number Title Priority Date Filing Date
DK209188A DK170741B1 (da) 1987-04-16 1988-04-15 Bifunktionelle proteiner, deres fremstilling, et lægemiddel deraf og anvendelse deraf til fremstilling af et lægemiddel

Country Status (20)

Country Link
EP (1) EP0288809B1 (da)
JP (1) JP2667193B2 (da)
KR (1) KR970000187B1 (da)
AR (1) AR242991A1 (da)
AT (1) ATE79135T1 (da)
AU (1) AU613022B2 (da)
CA (1) CA1322157C (da)
DE (2) DE3712985A1 (da)
DK (1) DK170741B1 (da)
ES (1) ES2033981T3 (da)
FI (1) FI98830C (da)
GR (1) GR3006141T3 (da)
HU (1) HU204303B (da)
IE (1) IE61574B1 (da)
IL (1) IL86086A (da)
NO (1) NO176922C (da)
NZ (1) NZ224247A (da)
PH (1) PH25327A (da)
PT (1) PT87237B (da)
ZA (1) ZA882659B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5662896A (en) * 1988-03-21 1997-09-02 Chiron Viagene, Inc. Compositions and methods for cancer immunotherapy
US5225538A (en) * 1989-02-23 1993-07-06 Genentech, Inc. Lymphocyte homing receptor/immunoglobulin fusion proteins
US5116964A (en) * 1989-02-23 1992-05-26 Genentech, Inc. Hybrid immunoglobulins
US6406697B1 (en) 1989-02-23 2002-06-18 Genentech, Inc. Hybrid immunoglobulins
WO1990012877A1 (en) * 1989-04-19 1990-11-01 Cetus Corporation Multifunctional m-csf proteins and genes encoding therefor
US5073627A (en) * 1989-08-22 1991-12-17 Immunex Corporation Fusion proteins comprising GM-CSF and IL-3
WO1991002754A1 (en) * 1989-08-22 1991-03-07 Immunex Corporation Fusion proteins comprising gm-csf and il-3
US5108910A (en) * 1989-08-22 1992-04-28 Immunex Corporation DNA sequences encoding fusion proteins comprising GM-CSF and IL-3
US5376367A (en) * 1991-11-22 1994-12-27 Immunex Corporation Fusion proteins comprising MGF and IL-3
US5723125A (en) * 1995-12-28 1998-03-03 Tanox Biosystems, Inc. Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide
ES2590912T3 (es) 1997-12-08 2016-11-24 Merck Patent Gmbh Proteínas de fusión heterodiméricas útiles para inmunoterapia dirigida y estimulación general del sistema inmunitario
SK782002A3 (en) 1999-07-21 2003-08-05 Lexigen Pharm Corp FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
AU778611B2 (en) 1999-08-09 2004-12-16 Merck Patent Gmbh Multiple cytokine-antibody complexes
WO2001040311A1 (fr) * 1999-11-30 2001-06-07 Shionogi & Co., Ltd. Proteine fusionnee de chimiokine slc-il2
JP5179689B2 (ja) 2000-02-11 2013-04-10 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗体ベース融合タンパク質の循環系内半減期の増強
PL206701B1 (pl) 2001-03-07 2010-09-30 Merck Patent Gmbh Immunoglobulinowe białko fuzyjne, kodujący je kwas nukleinowy, replikujący wektor ekspresji zawierający taki kwas nukleinowy, eukariotyczna komórka gospodarza zawierająca taki wektor ekspresji oraz sposób zwiększania ekspresji takiego białka fuzyjnego
US6992174B2 (en) 2001-03-30 2006-01-31 Emd Lexigen Research Center Corp. Reducing the immunogenicity of fusion proteins
DE60239454D1 (de) 2001-05-03 2011-04-28 Merck Patent Gmbh Rekombinanter, tumorspezifischer antikörper und dessen verwendung
ES2516041T3 (es) 2001-10-10 2014-10-30 Ratiopharm Gmbh Remodelación y glicoconjugación de la hormona del crecimiento humano (hGH)
BR0214650A (pt) 2001-12-04 2005-05-03 Merck Patent Gmbh Imunocitoquinas com seletividade modulada
MXPA05006384A (es) 2002-12-17 2005-08-29 Merck Patent Gmbh Anticuerpo humanizado (h14.18) del anticuerpo 14.18 de raton enlazado a gd2 y su fusion con il-2.
ATE500267T1 (de) * 2003-07-21 2011-03-15 Transgene Sa Multifunktionelle cytokine
DE602004031341D1 (de) 2003-07-21 2011-03-24 Transgene Sa Multifunktionelle cytokine
WO2010001414A1 (en) * 2008-07-03 2010-01-07 Lupin Limited Expression of heterologous proteins in bacterial system using a gm-csf fusion tag

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985000817A1 (en) * 1983-08-10 1985-02-28 Amgen Microbial expression of interleukin ii
GB8327880D0 (en) * 1983-10-18 1983-11-16 Ajinomoto Kk Saccharomyces cerevisiae
EP0158198A1 (en) * 1984-03-29 1985-10-16 Takeda Chemical Industries, Ltd. DNA and use thereof
WO1985004673A1 (en) * 1984-04-10 1985-10-24 Takeda Chemical Industries, Ltd. Novel dna and its use
DE3419995A1 (de) * 1984-05-29 1985-12-05 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von human-interleukin-2 und mittel zur durchfuehrung dieses verfahrens
AU588819B2 (en) * 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
JPS61128889A (ja) * 1984-11-27 1986-06-16 Green Cross Corp:The 組換えｄｎａ及び該ｄｎａによる形質転換体
JPH0646957B2 (ja) * 1985-03-11 1994-06-22 武田薬品工業株式会社 インタ−ロイキン−２の製造方法
WO1987002060A1 (en) * 1985-10-03 1987-04-09 Biogen N.V. Human granulocyte-macrophage colony stimulating factor-like polypeptides and processes for producing them in high yields in microbial cells
DE3541856A1 (de) * 1985-11-27 1987-06-04 Hoechst Ag Eukaryotische fusionsproteine, ihre herstellung und verwendung sowie mittel zur durchfuehrung des verfahrens
DE3545568A1 (de) * 1985-12-21 1987-07-16 Hoechst Ag Gm-csf-protein, seine derivate, herstellung solcher proteine und ihre verwendung

Also Published As

Publication number Publication date
GR3006141T3 (da) 1993-06-21
FI98830C (fi) 1997-08-25
DK209188A (da) 1988-10-17
HU204303B (en) 1991-12-30
AU613022B2 (en) 1991-07-25
ZA882659B (en) 1988-10-14
FI881743A (fi) 1988-10-17
JPS63301898A (ja) 1988-12-08
NO881658L (no) 1988-10-17
AR242991A1 (es) 1993-06-30
ES2033981T3 (es) 1993-04-01
IL86086A0 (en) 1988-09-30
EP0288809A1 (de) 1988-11-02
EP0288809B1 (de) 1992-08-05
IE61574B1 (en) 1994-11-16
NO881658D0 (no) 1988-04-15
FI98830B (fi) 1997-05-15
NZ224247A (en) 1990-04-26
HUT47319A (en) 1989-02-28
CA1322157C (en) 1993-09-14
DE3712985A1 (de) 1988-11-03
JP2667193B2 (ja) 1997-10-27
DE3873397D1 (de) 1992-09-10
IE881146L (en) 1988-10-16
NO176922C (no) 1995-06-21
ATE79135T1 (de) 1992-08-15
KR880012760A (ko) 1988-11-29
PT87237B (pt) 1992-07-31
PT87237A (pt) 1988-05-01
PH25327A (en) 1991-04-30
IL86086A (en) 1995-01-24
NO176922B (no) 1995-03-13
FI881743A0 (fi) 1988-04-14
KR970000187B1 (ko) 1997-01-06
DK170741B1 (da) 1996-01-08
AU1466188A (en) 1988-10-20

Similar Documents

Publication Publication Date Title
DK209188A (da) Bifunktionelle proteiner, deres fremstilling og anvendelse som laegemiddel
DK374389D0 (da) Arylbenzenoxazolidinoner, deres fremstilling og anvendelse
DK139287D0 (da) Tertiaere hydroxyalkylxanthiner, deres fremstilling og anvendelse som laegemidler
DK143588A (da) Substituerede 9-amino-tetrahydroacridiner, deres fremstilling og anvendelse som laegemidler
DK595388A (da) Benzopyranderivater, deres fremstilling og anvendelse
DK388989D0 (da) Acylcyanoguanidiner, deres fremstilling og anvendelse
DK435289A (da) Piperazindioner, deres fremstilling og anvendelse
DK193088A (da) 2-acylpyrrolidin-derivater, deres fremstilling og anvendelse
DK366888A (da) Castanosperminestre og -glykosider, deres fremstilling og anvendelse som laegemidler
DK278188D0 (da) Thiazolidin-4-on-derivater, deres fremstilling og anvendelse
DK698188D0 (da) Peptider, deres fremstilling og anvendelse
DK225089D0 (da) 2-adamantyl-4-isothiazolin-3-oner, deres fremstilling og anvendelse
DK189488D0 (da) Imidazothiadiazinderivater, deres fremstilling og anvendelse
DK627684A (da) 1,4-naphthoquinolinderivater, deres fremstilling og anvendelse som laegemiddel
DK162087D0 (da) Piperidinforbindelser, deres fremstilling og anvendelse
DK42888D0 (da) Arylthiadiazolylsulfonamider og derivater deraf, deres fremstilling og anvendelse som laegemiddel
DK223288A (da) Benzensulfornamid-derivater, deres fremstilling og anvendelse
DK501888A (da) 6-mercaptopurin-derivater, deres fremstilling og anvendelse som laegemidler
DK592389D0 (da) Penemderivater, deres fremstilling og anvendelse
DK412188A (da) Benzothiazinon-derivater, deres fremstilling og anvendelse
DK613888A (da) Acyllabdan-derivater, deres fremstilling og anvendelse
DK361388D0 (da) Cephemderivater, deres fremstilling og anvendelse
DK668888A (da) Labdan-derivater, deres fremstilling og anvendelse
DK668788D0 (da) Labdanderivater, deres fremstilling og anvendelse
DK161022C (da) Imidazoquinoxalinforbindelser, deres fremstilling og farmaceutiske praeparater, der indeholder forbindelserne

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK